Basit öğe kaydını göster

dc.contributor.authorMaher, Eamonn R.
dc.contributor.authorKhan, Ayesha
dc.contributor.authorAyub, Qasim
dc.contributor.authorSultana, Salma
dc.contributor.authorMehdi, Syed Qasim
dc.contributor.authorKhaliq, Shagufta
dc.contributor.authorAbid, Aiysha
dc.contributor.authorWhite, Dominick R. A.
dc.contributor.authorJohnson, Colin A.
dc.contributor.authorIsmail, Muhammad
dc.date.accessioned2022-02-18T10:27:47Z
dc.date.available2022-02-18T10:27:47Z
dc.date.issued2007
dc.identifier.citationKhaliq S., Abid A., White D. R. A. , Johnson C. A. , Ismail M., Khan A., Ayub Q., Sultana S., Maher E. R. , Mehdi S. Q. , "Mapping of a novel type III variant of Knobloch syndrome (KNO3) to chromosome 17q11.2", AMERICAN JOURNAL OF MEDICAL GENETICS PART A, cilt.143A, sa.23, ss.2768-2774, 2007
dc.identifier.issn1552-4825
dc.identifier.otherav_9f11ef28-2370-410d-95f3-d48cbe766932
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/179304
dc.identifier.urihttps://doi.org/10.1002/ajmg.a.31739
dc.description.abstractKnobloch syndrome (KNO) is an autosomal recessive disorder characterized by ocular abnormalities (myopia and retinal detachment) and occipital encephalocele. The syndrome is clinically and genetically heterogeneous (KNO1, KNO2). Previously germline mutations in COL18A1 (21q22.3) were detected in some families, but in other kindreds linkage to COL18A1 was excluded. We ascertained a large consanguineous family with high myopia, vitreoretinal degeneration and occipital scalp defect with autosomal recessive mode of inheritance. Due to the overlapping clinical presentation of this family with Knobloch syndrome we propose this phenotype as a type III variant of KS (KNO3). A genome wide linkage study using microsatellite markers at 10-20 cM interval revealed linkage to 17q11.2 with a Maximum LOD scores 3.40 (theta = 0.00) for markers D17S1307 and D17S1166. Fine mapping defined a 2.67 cM disease region between D17S1307 and D17S798. Mutation analysis of three candidate genes (UNC119, MYO1D, and RAB11FIP4) within the disease region did not identify any disease-associated mutation in affected individuals. (C) 2007 Wiley-Liss, Inc.
dc.language.isoeng
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTemel Bilimler
dc.subjectGenetics
dc.subjectMolecular Biology
dc.subjectGenetics (clinical)
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectGENETİK VE HAYAT
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Genetik
dc.subjectYaşam Bilimleri
dc.titleMapping of a novel type III variant of Knobloch syndrome (KNO3) to chromosome 17q11.2
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF MEDICAL GENETICS PART A
dc.contributor.department, ,
dc.identifier.volume143A
dc.identifier.issue23
dc.identifier.startpage2768
dc.identifier.endpage2774
dc.contributor.firstauthorID3375199


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster